We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.
BLPH

Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of BLPH yet.

BLPH Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q1 2024, worth a combined $0 — down 100% from $6.37K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BLPH and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Acadian Asset Management, exiting entirely with an estimated $6K sold.

  • 0 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q1 2024, down from 2 in Q4 2023.
  • Funds reported $0 of Bellerophon Therapeutics, Inc. stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Bellerophon Therapeutics, Inc. positions in Q1 2024 and 2 closed out, a net change of -2 holders.
  • The largest Bellerophon Therapeutics, Inc. seller in Q1 2024 was Acadian Asset Management, an estimated $6K sold.

Based on aggregated 13F filings for Q1 2024.